Kimberly Chong

Array ( [id] => 6499307 [patent_doc_number] => 20100209933 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-08-19 [patent_title] => 'Methods and Compositions for Detection and Enrichment of Target Small RNAs' [patent_app_type] => utility [patent_app_number] => 12/738580 [patent_app_country] => US [patent_app_date] => 2008-10-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 20 [patent_no_of_words] => 8157 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0209/20100209933.pdf [firstpage_image] =>[orig_patent_app_number] => 12738580 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6267763 [patent_doc_number] => 20100298411 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-11-25 [patent_title] => 'LIPID-MODIFIED DOUBLE-STRANDED RNA HAVING POTENT RNA INTERFERENCE EFFECT' [patent_app_type] => utility [patent_app_number] => 12/738797 [patent_app_country] => US [patent_app_date] => 2008-10-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 13001 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0298/20100298411.pdf [firstpage_image] =>[orig_patent_app_number] => 12738797 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6234875 [patent_doc_number] => 20100266579 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-10-21 [patent_title] => 'TREATMENT OF INFLAMMATORY DISEASES' [patent_app_type] => utility [patent_app_number] => 12/738920 [patent_app_country] => US [patent_app_date] => 2008-10-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 11330 [patent_no_of_claims] => 41 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0266/20100266579.pdf [firstpage_image] =>[orig_patent_app_number] => 12738920 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6448814 [patent_doc_number] => 20100280098 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-11-04 [patent_title] => 'RECEPTOR TARGETED OLIGONUCLEOTIDES' [patent_app_type] => utility [patent_app_number] => 12/681260 [patent_app_country] => US [patent_app_date] => 2008-10-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 29 [patent_figures_cnt] => 29 [patent_no_of_words] => 19643 [patent_no_of_claims] => 37 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0280/20100280098.pdf [firstpage_image] =>[orig_patent_app_number] => 12681260 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5534195 [patent_doc_number] => 20090233983 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-09-17 [patent_title] => 'RNA Interference Mediated Inhibition of Protein Tyrosine Phosphatase-1B (PTP-1B) Gene Expression Using Short Interfering RNA' [patent_app_type] => utility [patent_app_number] => 12/245486 [patent_app_country] => US [patent_app_date] => 2008-10-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 33524 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0233/20090233983.pdf [firstpage_image] =>[orig_patent_app_number] => 12245486 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8870895 [patent_doc_number] => 08466273 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-06-18 [patent_title] => 'Hepatitis C virus inhibitors' [patent_app_type] => utility [patent_app_number] => 12/241868 [patent_app_country] => US [patent_app_date] => 2008-09-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 6665 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 31 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12241868 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6245712 [patent_doc_number] => 20100136026 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-06-03 [patent_title] => 'Ship Inhibition to Direct Hematopoietic Stem Cells and Induce Extramedullary Hematopoiesis' [patent_app_type] => utility [patent_app_number] => 12/670360 [patent_app_country] => US [patent_app_date] => 2008-09-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 23 [patent_figures_cnt] => 23 [patent_no_of_words] => 29376 [patent_no_of_claims] => 42 [patent_no_of_ind_claims] => 21 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0136/20100136026.pdf [firstpage_image] =>[orig_patent_app_number] => 12670360 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6577665 [patent_doc_number] => 20100273858 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-10-28 [patent_title] => 'COMPOSITIONS COMPRISING STAT5 SIRNA AND METHODS OF USE THEREOF' [patent_app_type] => utility [patent_app_number] => 12/678708 [patent_app_country] => US [patent_app_date] => 2008-09-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 27224 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0273/20100273858.pdf [firstpage_image] =>[orig_patent_app_number] => 12678708 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6033478 [patent_doc_number] => 20110082185 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-04-07 [patent_title] => 'CANCER-TESTIS GENE SILENCING AGENTS AND USES THEREOF' [patent_app_type] => utility [patent_app_number] => 12/678535 [patent_app_country] => US [patent_app_date] => 2008-09-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 15654 [patent_no_of_claims] => 36 [patent_no_of_ind_claims] => 14 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0082/20110082185.pdf [firstpage_image] =>[orig_patent_app_number] => 12678535 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5368797 [patent_doc_number] => 20090306356 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-12-10 [patent_title] => 'siRNA Targeting TNFalpha' [patent_app_type] => utility [patent_app_number] => 12/209698 [patent_app_country] => US [patent_app_date] => 2008-09-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 43 [patent_figures_cnt] => 43 [patent_no_of_words] => 34952 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0306/20090306356.pdf [firstpage_image] =>[orig_patent_app_number] => 12209698 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5272113 [patent_doc_number] => 20090075889 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-03-19 [patent_title] => 'IREN PROTEIN, ITS PREPARATION AND USE' [patent_app_type] => utility [patent_app_number] => 12/207269 [patent_app_country] => US [patent_app_date] => 2008-09-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 25 [patent_figures_cnt] => 25 [patent_no_of_words] => 24144 [patent_no_of_claims] => 40 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0075/20090075889.pdf [firstpage_image] =>[orig_patent_app_number] => 12207269 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5416411 [patent_doc_number] => 20090042298 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-02-12 [patent_title] => 'COMPOSITIONS AND METHODS FOR ENHANCING DELIVERY OF NUCLEIC ACIDS INTO CELLS AND FOR MODIFYING EXPRESSION OF TARGET GENES IN CELLS' [patent_app_type] => utility [patent_app_number] => 12/206165 [patent_app_country] => US [patent_app_date] => 2008-09-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 23416 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0042/20090042298.pdf [firstpage_image] =>[orig_patent_app_number] => 12206165 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9250530 [patent_doc_number] => 08614309 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-12-24 [patent_title] => 'Double-stranded RNA directed to CASP2 and methods of use thereof' [patent_app_type] => utility [patent_app_number] => 12/733998 [patent_app_country] => US [patent_app_date] => 2008-09-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 79 [patent_figures_cnt] => 57 [patent_no_of_words] => 42901 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 10 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12733998 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 169006 [patent_doc_number] => 07667029 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-02-23 [patent_title] => 'RNA interference mediated inhibition of checkpoint kinase-1 (CHK-1) gene expression using short interfering nucleic acid (siNA)' [patent_app_type] => utility [patent_app_number] => 12/203669 [patent_app_country] => US [patent_app_date] => 2008-09-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 25 [patent_figures_cnt] => 25 [patent_no_of_words] => 60776 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 49 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/667/07667029.pdf [firstpage_image] =>[orig_patent_app_number] => 12203669 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7589368 [patent_doc_number] => 07662952 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-02-16 [patent_title] => 'RNA interference mediated inhibition of GRB2 associated binding protein (GAB2) gene expression using short interfering nucleic acid (siNA)' [patent_app_type] => utility [patent_app_number] => 12/203029 [patent_app_country] => US [patent_app_date] => 2008-09-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 25 [patent_figures_cnt] => 25 [patent_no_of_words] => 65306 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 49 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/662/07662952.pdf [firstpage_image] =>[orig_patent_app_number] => 12203029 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9273545 [patent_doc_number] => 08637477 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-01-28 [patent_title] => 'Antigenic compositions and use of same in the targeted delivery of nucleic acids' [patent_app_type] => utility [patent_app_number] => 12/675560 [patent_app_country] => US [patent_app_date] => 2008-08-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 28 [patent_figures_cnt] => 37 [patent_no_of_words] => 9495 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 166 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12675560 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6026491 [patent_doc_number] => 20110054011 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-03-03 [patent_title] => 'RNA Antagonist Compounds for the Modulation of FABP4/AP2' [patent_app_type] => utility [patent_app_number] => 12/675676 [patent_app_country] => US [patent_app_date] => 2008-08-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 16382 [patent_no_of_claims] => 69 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0054/20110054011.pdf [firstpage_image] =>[orig_patent_app_number] => 12675676 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5474440 [patent_doc_number] => 20090247606 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-10-01 [patent_title] => 'RNA Interference Mediated Inhibition of Adenosine A1 Receptor (ADORA1) Gene Expression Using Short Interfering Nucleic Acid (siNA)' [patent_app_type] => utility [patent_app_number] => 12/200693 [patent_app_country] => US [patent_app_date] => 2008-08-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 35176 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0247/20090247606.pdf [firstpage_image] =>[orig_patent_app_number] => 12200693 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5355501 [patent_doc_number] => 20090186845 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-07-23 [patent_title] => 'INTERFERING RNA MOLECULES' [patent_app_type] => utility [patent_app_number] => 12/200296 [patent_app_country] => US [patent_app_date] => 2008-08-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 30 [patent_figures_cnt] => 30 [patent_no_of_words] => 18613 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0186/20090186845.pdf [firstpage_image] =>[orig_patent_app_number] => 12200296 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6388995 [patent_doc_number] => 20100317722 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-12-16 [patent_title] => 'NUCLEIC ACID SEQUENCES COMPRISING NF-kB BINDING SITE WITHIN O(6)-METHYLGUANINE-DNA-METHYLTRANSFERASE (MGMT) PROMOTER REGION AND USES THEREOF FOR THE TREATMENT OF CANCER AND IMMUNE-RELATED DISORDERS' [patent_app_type] => utility [patent_app_number] => 12/674536 [patent_app_country] => US [patent_app_date] => 2008-08-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 19367 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0317/20100317722.pdf [firstpage_image] =>[orig_patent_app_number] => 12674536 [rel_patent_id] =>[rel_patent_doc_number] =>)